• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis With Certolizumab Pegol: 96-Week Patient-Reported Outcome Results Of The Rapid-Psa Study.

作者信息

Gladman D, Fleischmann R, Szegvari B, Peterson L, Mease P J

机构信息

Toronto Western Research Institute, Toronto, Ontario, ON, Canada.

Metroplex Clinical Research Center, Dallas, TX, USA.

出版信息

Value Health. 2014 Nov;17(7):A386. doi: 10.1016/j.jval.2014.08.2646. Epub 2014 Oct 26.

DOI:10.1016/j.jval.2014.08.2646
PMID:27200875
Abstract
摘要

相似文献

1
Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis With Certolizumab Pegol: 96-Week Patient-Reported Outcome Results Of The Rapid-Psa Study.聚乙二醇化赛妥珠单抗对银屑病关节炎多方面改善的长期维持：RAPID-PsA研究96周患者报告结局结果
Value Health. 2014 Nov;17(7):A386. doi: 10.1016/j.jval.2014.08.2646. Epub 2014 Oct 26.
2
Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.培塞丽珠单抗持续治疗可使克罗恩病患者的缓解期长达 18 个月。
Clin Gastroenterol Hepatol. 2010 Jul;8(7):600-9. doi: 10.1016/j.cgh.2010.01.014. Epub 2010 Feb 1.
3
Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study.
Value Health. 2014 Nov;17(7):A385-6. doi: 10.1016/j.jval.2014.08.2643. Epub 2014 Oct 26.
4
Certolizumab pegol for the treatment of psoriatic arthritis.聚乙二醇化赛妥珠单抗用于治疗银屑病关节炎。
Expert Rev Clin Immunol. 2015 Mar;11(3):307-18. doi: 10.1586/1744666X.2015.1009897. Epub 2015 Feb 5.
5
Maintenance therapy with certolizumab pegol for Crohn's disease.聚乙二醇化赛妥珠单抗用于克罗恩病的维持治疗。
N Engl J Med. 2007 Jul 19;357(3):239-50. doi: 10.1056/NEJMoa062897.
6
Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 Study.在复发的克罗恩病患者中使用培塞丽珠单抗进行再诱导：来自 PRECiSE 4 研究的结果。
Clin Gastroenterol Hepatol. 2010 Aug;8(8):696-702.e1. doi: 10.1016/j.cgh.2010.03.024. Epub 2010 Apr 2.
7
Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn's disease with prior loss of response to infliximab.随机临床试验：在对英夫利昔单抗治疗应答丧失的活动性克罗恩病患者中，培塞丽珠单抗治疗可改善健康结局。
Aliment Pharmacol Ther. 2011 Mar;33(5):541-50. doi: 10.1111/j.1365-2036.2010.04568.x. Epub 2011 Jan 12.
8
Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn's disease in the PRECiSE 2 study.临床试验：PRECiSE 2 研究中，培塞利珠单抗治疗对中重度克罗恩病患者工作生产力的影响。
Aliment Pharmacol Ther. 2010 Jun;31(12):1276-85. doi: 10.1111/j.1365-2036.2010.04303.x. Epub 2010 Mar 18.
9
Correction: .更正：.
RMD Open. 2018 Mar 26;4(1). doi: 10.1136/rmdopen-2017-000582corr1. eCollection 2018.
10
Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis.使用生物荧光成像比较赛妥珠单抗聚乙二醇化制剂、阿达木单抗和英夫利昔单抗在胶原诱导性关节炎小鼠炎症爪子中的分布。
J Immunol Methods. 2009 Aug 31;348(1-2):36-41. doi: 10.1016/j.jim.2009.06.009. Epub 2009 Jun 28.

引用本文的文献

1
Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis.用于治疗银屑病关节炎的肿瘤坏死因子（TNF）抑制剂。
Cochrane Database Syst Rev. 2025 Feb 13;2(2):CD013614. doi: 10.1002/14651858.CD013614.pub2.
2
Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis.生物制剂治疗银屑病关节炎的疗效和安全性：系统文献回顾和网络荟萃分析。
RMD Open. 2020 Feb;6(1). doi: 10.1136/rmdopen-2019-001117.
3
Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data.
聚乙二醇化赛妥珠单抗治疗银屑病和银屑病关节炎：初步真实世界数据
Dermatol Ther (Heidelb). 2017 Dec;7(4):485-492. doi: 10.1007/s13555-017-0208-z. Epub 2017 Nov 14.
4
Certolizumab pegol: a review of its use in patients with axial spondyloarthritis or psoriatic arthritis.注射用培塞利珠单抗：在治疗中轴型脊柱关节炎或银屑病关节炎患者中的应用评价。
Drugs. 2014 Jun;74(9):999-1016. doi: 10.1007/s40265-014-0239-z.